Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ASCO 2021
Pharma
AZ details Calquence's heart safety edge over Imbruvica
Significantly fewer Calquence patients suffered atrial fibrillation than Imbruvica patients did in a head-to-head trial.
Angus Liu
Jun 7, 2021 3:10pm
Gilead treads on Novartis' CAR-T turf with Tecartus ALL win
Jun 4, 2021 2:30pm
Novartis' Lutathera relegated to 'clinically relevant' survival
Jun 4, 2021 11:16am
BMS touts 2 Opdivo GI cancer wins, with one Yervoy caveat
Jun 3, 2021 5:00pm
Keytruda targets Pfizer's Sutent in adjuvant kidney cancer
Jun 3, 2021 5:00pm
AZ, Merck's Lynparza touts big win in early breast cancer
Jun 3, 2021 5:00pm